Reconsidering prostate cancer screening
In 2011, the US Preventive Services Task Force (USPSTF) issued its controversial draft recommendation against measuring prostate-specific antigen (PSA) in blood to screen for prostate cancer, claiming the test didn’t save lives. USPSTF is an independent panel of national experts convened by Congress to make evidence-based recommendations on preventive care.